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Migraine is a common neurological disorder and can be severely disabling during attacks. The 
highest prevalence occurs between the ages of 25 and 55 years, potentially the most productive 
period of life. Migraine leads to a burden not only for the individual, but also for the family and 
society in general. Prior studies have found that migraine occurs together with other illnesses 
at a greater coincidental rate than is seen in the general population. These occurrences are 
called “comorbidities, ” which means that these disorders are interrelated with migraine. To 
delineate the comorbidities of migraine is important, because it can help improve treatment 
strategies and the understanding of the possible pathophysiology of migraine. The comorbid 
illnesses in patients with migraine include stroke, sub-clinical vascular brain lesions, coronary 
heart disease, hypertension, patent foramen ovale, psychiatric diseases (depression, anxiety, 
bipolar disorder, panic disorder, and suicide), restless legs syndrome, epilepsy and asthma. In 
this paper, we review the existing epidemiological and hospital-based studies, and illustrate 
the connections between these illnesses and migraine.
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relationship between migraine and stroke, sub-clinical vascular 
brain  lesions,  coronary  artery  disease,  hypertension  and  PFO. 
Table 1 summarizes the studies of CVD and migraine.
Stroke
The association between migraine and ischemic stroke has been 
well  known  from  many  case-control  and  cohort  studies.  The 
Atherosclerosis Risk in Communities Study in the United States 
(Stang et al., 2005) recorded the life-time headache history of par-
ticipants by using the modified International Headache Society 
(IHS) diagnostic criteria, and the stroke events were identified and 
validated using medical records. The results showed migraine with 
aura was associated with stroke symptoms [odds ratio (OR) 5.46], 
transient ischemic attack (TIA) symptoms (OR 4.28), and veri-
fied ischemic stroke events (OR 2.81). Another important piece of 
evidence came from a prospective analysis on the risk of ischemic 
stroke in the Women’s Health Study (Kurth et al., 2005). Nearly 
40,000 healthy females aged 45 years and older, and without a his-
tory of stroke, TIA or an abnormal neurological examination, were 
followed up for a mean of 9 years. Migraine and aura were based 
on self-report. In this prospective study, migraine with aura was 
associated with incidents of ischemic stroke [Hazard ratio (HR) 
1.70], with the risks most evident for those under 55 years of age 
at baseline (HR 2.25). In the subgroup of Women’s Health Study 
(Kurth et al., 2006), after adjustment of the risk factors for major 
CVD including age, blood pressure, antihypertensive medication, 
diabetes, body mass index (BMI), smoking, alcohol consumption, 
menstrual status, hormone levels, oral contraceptive use and cho-
lesterol, active migraine with aura was associated with an increased 
risk of ischemic stroke. Importantly, women who reported active 
migraine without aura were not significantly related to an increased 
IntroductIon
Migraine  is  one  of  the  most  common  neurological  disorders 
(Andlin-Sobocki et al., 2005). It causes substantial levels of dis-
ability; however, the burden of migraine is underestimated in scope 
and scale. In most countries, migraine is under-recognized and 
under-treated (Stewart et al., 1992; Wang et al., 2000).
The term comorbidity is used to refer to the statistical asso-
ciation of two distinct diseases in the same individual at a rate 
higher than expected by chance (Lipton and Silberstein, 1994). 
Many illnesses are reported to be comorbid with migraine (Scher 
et al., 2005a), which stresses the clinical complexity of this head-
ache disorder. Comorbidity in migraine is important from several 
perspectives: (1) co-occurrence of diseases can complicate the 
diagnosis, e.g., focal sign of migraine and stroke; (2) one disease 
can remind the clinicians of the other diseases, e.g., migraine and 
restless legs syndrome (RLS); (3) one treatment for two diseases, 
e.g., tricyclic antidepressants for migraine patients with depressive 
disorders; and (4) comorbidity of illnesses can provide clues to the 
pathophysiology of migraine.
This  review  focuses  on  the  findings  of  common  comorbid 
disorders of migraine, which include stroke, sub-clinical vascular 
brain lesions, coronary heart disease, hypertension, patent foramen 
ovale (PFO), psychiatric diseases, RLS, obesity, epilepsy, asthma 
and other disorders.
coMorBIdItY oF MIGrAInE
cArdIovAsculAr dIsordErs (cvd)
The vascular component of CVD is suspected to be part of the 
pathophysiology of migraine and led to the therapeutic develop-
ment of triptans. Many studies delineate the association between 
migraine and vascular problems. In this section, we focus on the Frontiers in Neurology  |  Headache Medicine and Facial Pain    August 2010  | Volume 1  | Article 16  |  2
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Table 1 | Summary of the studies of cardiovascular disorders (CVD) and migraine.
Study  Population  N  Results 
  (age at entry)
Migraine with aura Migraine without aura
ISCheMIC STRoKe aND TRaNSIeNT ISCheMIC aTTaCK (TIa)
Atherosclerosis Risk in 
Communities Study (Stang et al., 
2005)
Both sexes 
(45–64)
12,750 An association with stroke 
symptoms, TIA symptoms, and 
verified ischemic stroke events
Increased risk of stroke 
symptoms
Women’s Health Study (Kurth 
et al., 2005)
Women (≥45) 39,717 An association with ischemic stroke No association with ischemic 
stroke
Women’s Health Study (Kurth 
et al., 2006)
Women (≥45) 27 ,840 An association with ischemic stroke No association with ischemic 
stroke
Women’s Health Study (Kurth 
et al., 2008)
Women (≥45) 27 ,519 An association with ischemic stroke 
only in the low Framingham risk 
score group
No association with ischemic 
stroke in any of the Framingham 
risk score groups
Physicians’ Health Study (Kurth 
et al., 2007)
Men (40–84) 20,084 The age-adjusted HR of ischemic 
stroke was increased in men with 
migraine younger than 55 years
American Migraine Prevalence 
and Prevention (AMPP) study 
(Bigal et al., 2010)
Both sexes 
(≥45)
11,345 (6102 
migraine and 
5243 controls)
An association with CVD and risk 
factors for CVD
An association with CVD and of 
risk factors for CVD
Sub-ClINICal CeRebRal leSIoNS
Cerebral Abnormalities in 
Migraine, an Epidemiological 
Risk Analysis (CAMERA) study 
(Kruit et al., 2004)
Both sexes 
(30–60)
161 migraine 
with aura, 134 
migraine 
without aura, 
140 controls
An association with the posterior 
circulation territory infarcts
No association with the posterior 
circulation infarcts
AGES-Reykjavik Study (Scher 
et al., 2009)
Both sexes 
(33–65)
4,689 An association with cerebellar 
infarct-like lesions in women, but not 
men
No association with cerebellar 
infarct-like lesions
CoRoNaRy heaRT DISeaSe
Atherosclerosis Risk in 
Communities Study (Rose et al., 
2004)
Both sexes 
(45–64)
12,409 Rose angina was more frequent in 
migraine patients, and the 
associations were stronger for 
migraine with aura. The risk of 
coronary heart disease did not 
increase in migraine patients
Women’s Health Study (Kurth 
et al., 2006)
Women (≥45) 27 ,840 An association with myocardial 
infarction, angina, and coronary 
revascularization
No association with myocardial 
infarction, angina, and coronary 
revascularization
Physicians’ Health Study (Kurth 
et al., 2007)
Men (40–84) 20,084 Men with migraine were driven by 
42% increase in the risk of 
myocardial infarction, and 24% 
increased risk for major CVD after 
adjusted cardiovascular risk factors
American Migraine Prevalence 
and Prevention (AMPP) study 
(Bigal et al., 2010)
Both sexes 
(≥45)
11,345 (6102 
migraine and 
5243 controls)
An association with myocardial 
infarction
An association with myocardial 
infarction
risk of ischemic stroke in this study. Furthermore, a recent report 
from the same group also showed the association between ischemic 
stroke and active migraine with aura in women only in the low 
Framingham risk score group (10-year risk of coronary heart dis-
ease < 1%, HR: 3.88; 95% CI, 1.87–8.08) (Kurth et al., 2008). In 
consideration of the individual components of the Framingham 
risk score, this diametric pattern of association was driven by a par-
ticularly increased risk of ischemic stroke among women with active 
migraine with aura who were young (aged 45–49) and had low 
total cholesterol concentrations. With regard to men,   prospective www.frontiersin.org  August 2010  | Volume 1  | Article 16  |  3
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Hypertension and other CVD risk factor
Reports on the relationship between migraine and hypertension 
are controversial. The positive association was noted in two clinic-
based studies (Franceschi et al., 1997; Cirillo et al., 1999), and no 
association in one population-based study (Rasmussen and Olesen, 
1992). Actually, two prospective population-based studies demon-
strated a negative association between migraine and hypertension 
(Wiehe et al., 2002; Tzourio et al., 2003). The CVD risk factors 
were recorded in several population-based studies to evaluate the 
associations between migraine, and stroke or coronary artery dis-
ease. The GEM study (Scher et al., 2005b) and AMPP sub-study 
(Bigal et al., 2010) demonstrated a higher cardiovascular risk profile 
in migraineurs with higher cholesterol and blood pressure levels. 
However, this result was not confirmed in the Women’s Health 
Study (Kurth et al., 2006). Further studies are needed to confirm 
the relationship between blood pressure and other CVD risk factors 
in migraine patients.
Gene polymorphisms
Two important gene polymorphisms were studied in both migraine 
and CVD: the 677C > T polymorphism of the methylenetetrahy-
drofolate reductase (MTHFR) gene, and the D/I polymorphism 
of the angiotensin-converting enzyme (ACE) gene. The MTHFR 
677C > T polymorphism was investigated in the Women’s Health 
Study (Schürks et al., 2008). The study found that the 677TT geno-
type was associated with a 20% reduced risk for migraine with aura 
(RR = 0.79; 95% CI, 0.65–0.96; p = 0.02), but was not associated with 
ischemic stroke or myocardial infarction. However, co-existence of 
migraine with aura and the 677TT genotype further increases the 
risk for major CVD (HR = 3.66; 95% CI = 1.69–7.90; p = 0.001). 
This pattern was only apparent in ischemic stroke (HR = 4.19; 
95% CI = 1.38–12.74; p = 0.01), but not in myocardial infarction 
(HR = 2.88; 95% CI = 0.84–9.88; p = 0.09). The ACE D/I polymor-
phism was studied in the same cohort (Schürks et al., 2009). There is 
no association between the ACE D/I polymorphism, and migraine 
or CVD. However, the risk of CVD was doubled in migraine with 
aura patients, but only for carriers of the DD/DI genotype. The risk 
was not increased among carriers of the II genotype. Due to the 
limited number of outcome events, future studies are warranted 
to further investigate this association.
Patent foramen ovale (PFO)
An association between PFO and migraine has been identified in 
many studies (Del Sette et al., 1998; Anzola et al., 1999; Ferrarini 
et al., 2005; Schwerzmann et al., 2005; Carod-Artal et al., 2006). 
It is hypothesized that right-to-left shunts via PFO may allow 
for  paradoxical  embolism,  and  passage  of  higher  concentra-
tions of vasoactive substances into the cerebral arterial system 
(Buzzi and Moskowitz, 2005; Schwedt and Dodick, 2006). In 
most studies, PFO is common in patients with migraine with 
aura (Del Sette et al., 1998; Anzola et al., 1999; Ferrarini et al., 
2005; Schwerzmann et al., 2005), and some retrospective stud-
ies suggest that PFO closure is effective for migraine treatment 
(Post et al., 2004; Schwerzmann et al., 2004). However, several 
studies reported different results: in a cross-sectional study from 
the  Northern  Manhattan  Study  (NOMAS),  1101  stroke-free 
precipitants aged > 39-years old (mean 69±10-years old) were 
data from the Physicians’ Health Study investigated the association 
between migraine and CVD in men (Kurth et al., 2007). In this 
study, 20,084 apparently healthy US male physicians aged 40–84 at 
study entry were followed for a mean of 15.7 years. The age-adjusted 
HR of ischemic stroke was increased in men with migraine younger 
than 55 years [relative risk (RR): 1.84; 95% CI: 1.10–3.08]. This 
association was not found in older age groups. One recent popu-
lation-based study [part of the American Migraine Prevalence and 
Prevention (AMPP) study] found a positive association between 
migraine with aura and stroke in both adult men and women (Bigal 
et al., 2010). After adjustment for age, gender, disability, treatment 
and CVD risk factors, migraine with aura remained significantly 
associated with stoke (Bigal et al., 2010).
Sub-clinical vascular brain lesions
Sub-clinical cerebral lesions, especially in the posterior circulation 
or white matter, were reported to be more frequent in patients with 
migraine (especially migraine with aura) in a case-controlled MRI 
study (CAMERA) (Kruit et al., 2004). The same group also dem-
onstrated that most (88%) infratentorial infarct-like lesions had a 
vascular border zone location in the cerebellum and, further, that 
a combination of hypoperfusion (possibly migraine attack-related) 
and embolism is the most likely mechanism for posterior circula-
tion infarction in migraine (Kruit et al., 2005). Recently, MRI was 
performed in participants of the AGES-Reykjavik Study, more than 
26 years after the initial headache diagnosis. Women, but not men, 
with migraine with aura in midlife were associated with increased 
cerebellar infarct-like lesions in late life (Scher et al., 2009).
Coronary heart disease
The association between migraine and coronary artery disease 
was conflicting in several large scale population-based studies. 
Of 12,409 participants, the Atherosclerosis Risk in Communities 
Study evaluated the prevalence of Rose angina and coronary artery 
disease (Rose et al., 2004). After more than 10 years of follow-up, 
Rose angina was more frequent in migraine patients, and the 
associations were stronger for migraine with aura [prevalence 
ratio (PR):3.0, 95% CI: 2.4–3.7]. Nevertheless, the risk of coronary 
heart disease did not increase in migraine patients (Rose et al., 
2004). However, in the Women’s Health Study (Kurth et al., 2006), 
not only ischemic stroke, but also other major cardiovascular 
events, such as myocardial infarction, angina and coronary revas-
cularization, were reported to be related to migraine with aura. 
In contrast to ischemic stroke, the association between myocar-
dial infarction and active migraine with aura was demonstrated 
only in those with a high Framingham risk score (10-year risk 
of coronary heart disease > 10%, HR: 3.34; 95% CI, 1.50–7.46), 
particularly among women with high total cholesterol concentra-
tions (Kurth et al., 2008). In the Physicians’ Health Study (Kurth 
et al., 2007), men with migraine demonstrated a 42% increase 
in the risk of myocardial infarction and a 24% increased risk 
for major CVD after adjustment for the cardiovascular risk fac-
tors. Recently, the AMPP sub-study in adults of both genders 
showed both migraine with and without aura were associated 
with myocardial infarction (OR: 2.86 vs. 1.85, respectively) after 
adjustment for gender, age, disability, treatment and CVD risk 
factors (Bigal et al., 2010).Frontiers in Neurology  |  Headache Medicine and Facial Pain    August 2010  | Volume 1  | Article 16  |  4
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major depressive disorder (OR 25.1) (Tietjen et al., 2007). We used 
a 30-item version of the Chinese Health Questionnaire (CHQ-30) 
to screen minor psychiatric morbidity if the score was > 10 in a 
Taiwan population. The study showed that subjects with chronic 
migraine had a higher chance to have a positive screening result 
in the CHQ-30 score (>10) than those with chronic tension-type 
headache (CTTH) (66% vs. 36%) (Lu et al., 2001). In clinic-based 
studies, patients with chronic daily headache, especially chronic 
migraine, had high frequencies of major depression and panic 
disorders (Juang et al., 2000). In addition, the presence of major 
depression was a poor outcome predictor in patients with chronic 
daily headache (RR = 1.8) (Lu et al., 2000).
Generalized anxiety disorder
The association between anxiety and migraine was noted in both 
clinic  and  community-based  studies  (Merikangas  et  al.,  1990; 
Breslau et al., 1991; Smoller et al., 2003; McWilliams et al., 2004). 
The study conducted by McWilliams and his colleagues also showed 
the association between migraine and anxiety: 9.1% of subjects with 
migraine have GAD, compared to 2.5% of those without migraine 
(OR = 3.9) (McWilliams et al., 2004). In the epidemiology cohort 
study in Zurich, the prevalence of GAD was high (OR = 5.3). The 
authors suggested that migraine with anxiety and depression may 
constitute a distinct syndrome comprising anxiety, often mani-
fested in early childhood, followed by the occurrence of migraine 
headaches, and then by discrete episodes of depressive disorders 
in adulthood (Merikangas et al., 1990).
Panic disorder
A high frequency of panic disorders was noted in patients with 
migraine (Breslau et al., 1991) and vise versa (Stewart et al., 1989, 
1994; Marazziti et al., 1999). A population-based study evaluated 
the temporal relation of migraine and panic disorder (Breslau 
et al., 2001). In the study, the life-time prevalence of panic disorder 
was not only higher in subjects with migraine, but also in those 
with other severe headaches (compared to controls). In addition, 
  examined  by  transthoracic  echocardiography  for  PFO.  There 
was no difference in the prevalence of PFO between participants 
with and without migraine (Rundek et al., 2008). In the Migraine 
Intervention with STARFlex Technology (MIST) trial – a prospec-
tive, randomized, double-blind trial – the intractable migraine 
with aura patients with moderate or large right-to-left shunts 
were included (Dowson et al., 2008). Patients were randomized 
to receive transcatheter PFO closure with the STARFlex implant 
or a sham procedure. After a 6-month follow-up, there were no 
differences in migraine cessation rates between the two groups 
(primary outcome measures). However, excluding two outliers, 
the implant group demonstrated a greater reduction in the fre-
quency of migraine attacks. Another study found that people who 
have migraine with aura are more likely to experience migraine 
relief following PFO closure than people who have migraine 
without aura (Jesurum et al., 2008). However, more puzzlingly, 
migraine relief can occur even if residual shunting occurs after 
the PFO is closed. A meta-analysis using the system Grades of 
Recommendation  Assessment,  Development  and  Evaluation 
(GRADE) by Schwedt et al. (2008) showed the evidence was low 
for the higher prevalence of migraine in PFO patients based on 
11 observational studies, and the evidence was low to moderate 
for the higher prevalence of PFO in migraine patients based on 
seven observational studies. The efficacy of the closure of PFO 
in treatment of migraine was still not certain due to the major 
issue of the unclear definition of “improvement” in most studies 
(Schwedt et al., 2008).
PsYchIAtrIc dIsordErs
Psychiatric disorders are frequently comorbid with migraine, and 
result in a significant burden in patients with migraine including 
depression, anxiety disorder, bipolar disorder, and suicide ideation 
and attempt (Table 2).
Depression
In 1990, a Zürich prospective epidemiological cohort study on 
young adults aged 27 and 28 years evaluated the prevalence of 
psychiatric comorbidity in subjects with migraine. This study dem-
onstrated a strong association between migraine and depression 
(OR = 2.2) (Merikangas et al., 1990). A bidirectional association 
of migraine and depression were later found in three longitudi-
nal population-based studies (Breslau et al., 1994, 2000, 2003). In 
these, the risk of new onset migraine in people with depression 
ranged from 2.8 to 3.5. Conversely, the risk of new onset of depres-
sion in people with migraine ranged from 2.4 to 5.8. In another 
study, which used data from an adult US population to look at 
the  cross-sectional  associations  between  three  pain  conditions 
(migraine, arthritis and back pain) and three psychiatric disor-
ders [depression, generalized anxiety disorder (GAD) and panic 
attacks] (McWilliams et al., 2004), the associations between the 
three psychiatric disorders were roughly similar. In this population, 
28.5% of the migraine subjects were considered clinically depressed, 
while only 12.3% of subjects without migraine fit the same criteria 
(OR 2.8). Comorbidity with psychological distress was related to 
a poorer health-related quality of life in patients with migraine 
(Wang et al., 2001). In a recent study, patients with disabling chronic 
headache had high frequencies of somatic complaints (OR 8.6) and 
Table 2 | The odds ratios of comorbid psychiatric disorders in patients 
with migraine.
Psychiatric disorders  odds ratio
Major depression (Merikangas et al.,   2.2–3.14 
1990; Breslau et al., 2003)
Bipolar spectrum (Merikangas et al.,  2.9–7 .3 
1990; Breslau et al., 1991)
Any anxiety (Merikangas et al., 1990)  2.7
Panic disorder (Merikangas et al., 1990;   3.0–5.09 
Breslau et al., 2001)
General anxiety disorder (Merikangas et al.,  3.9–5.3 
1990; McWilliams et al., 2004)
Agoraphobia (Merikangas et al., 1990)  2.4
Social phobia (Merikangas et al., 1990)  3.4
Suicide attempt* (Breslau, 1992)  4.3
Suicide ideation* (Breslau, 1992;   1.79–2.4 
Wang et al., 2009)
*migraine with aura only.www.frontiersin.org  August 2010  | Volume 1  | Article 16  |  5
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2009). However, two other epidemiological studies found a positive 
association between migraine and increased BMI (Ford et al., 2008; 
Peterlin et al., 2010). It is noteworthy that the two positive studies 
used direct measurement of BMI; whereas, the two negative studies 
adopted self-report BMI values.
EPIlEPsY
The association between migraine and epilepsy is still controver-
sial. In some studies, a higher prevalence of migraine was noted 
in epilepsy patients, but some studies reported differently (Marks 
and Ehrenberg, 1993; Lipton et al., 1994; Karaali-Savrun et al., 
2002; Nuyen et al., 2006). The prior studies suggest a shared 
genetic link between epilepsy and migraine (Baykan et al., 2004; 
Deprez et al., 2007; Tikka-Kleemola et al., 2010). Migraine had 
been reported in one family with adult onset myoclonic epilepsy 
(Saka and Saygi, 2000) and in one family with autosomal reces-
sive idiopathic epilepsy (Baykan et al., 2004). A linkage analysis in 
a large Belgian family with occipitotemporal lobe epilepsy asso-
ciated with migraine with visual aura provided evidence for a 
novel epilepsy and migraine susceptibility locus on chromosome 
9q21–q22 (Deprez et al., 2007). A genome-wide linkage study in 36 
Finnish families with at least 2 family members having scintillating 
scotoma revealed the same locus for visual aura (Tikka-Kleemola 
et al., 2010). Intriguingly, one of the genes in this region, SCH3, 
is highly expressed in occipital and temporal lobes, and regulates 
the neuronal adaptation against environmental stress (Troglio 
et al., 2004).
chronIc PAIn dIsordErs
Several chronic pain disorders were reported to be associated with 
migraine. The Nord-Trøndelag Health Study (Hagen et al., 2002) 
noted that subjects with headache reported more musculoskeletal 
pain than those without. The risk was similar between migraine 
and non-migraine headache patients (OR = 1.9 vs. 1.8). However, 
headache frequency was a strong predictor for musculoskeletal 
pain. Von Korff et al. (2005) also found that patients with self-
reported chronic spine pain were associated with migraine with 
an OR of 5.2. Fibromyalgia was very common in patients with 
migraine with frequencies between 22 and 40%. (Peres et al., 2001; 
Ifergane et al., 2006; de Tommaso et al., 2009) The development 
of fibromyalgia was highly associated with migraine frequency. 
Patients  who  suffered  from  both  migraine  and  fibromyalgia 
reported a higher prevalence of insomnia, lower quality of life 
and more mental stress (Peres et al., 2001; de Tommaso et al., 
2009). It is interesting that the fibromyalgia was more frequent in 
female migraine patients than male patients (Ifergane et al., 2006; 
de Tommaso et al., 2009).
othEr coMorBId dIsordErs
Regarding asthma, one large epidemiological study (Head-Hunt 
study) performed in Norway reported that both migraine and 
non-migrainous headaches were related to asthma and chronic 
bronchitis (Aamodt et al., 2007). Of note, the association was more 
related to headache frequencies than headache diagnoses (Aamodt 
et al., 2007). But, in another study, the incidence of newly diag-
nosed asthma was not different between subjects with and without 
migraine (OR 1.17) (Becker et al., 2008). The association between 
the onset of panic disorder was significantly higher in subjects 
with migraine or severe headache (HR: 3.55 vs. 5.75, respectively). 
The onset of migraine or severe headache was also more frequent 
in subjects with panic disorder (HR: 2.10 vs. 1.85, respectively). 
The study indicates a higher frequency of panic disorder was not 
specifically in migraine patients but also in other severe headache 
patients. A bidirectional temporal relationship was found between 
headache and panic disorder with a stronger direction of headache 
to panic disorder (Breslau et al., 2001).
Bipolar disorders
The  number  of  studies  focusing  on  the  relationship  between 
migraine and bipolar disorders were much less than those for anxi-
ety and depression. Most of them were clinic-based (Younes et al., 
1986; Mahmood et al., 1999; Low et al., 2003). Two population-
based studies reported the positive association between migraine 
and bipolar disorders in young adults (OR: 2.9–7.3) (Merikangas 
et al., 1990; Breslau et al., 1991).
Suicide ideation and suicide attempt
Breslau et al. (1991) and Breslau (1992) first reported that a history 
of migraine with aura was associated with increased frequencies 
of suicidal ideation and suicide attempts in young adults. One of 
our community-based studies in Taiwan showed young adoles-
cents with CDH had a high frequency of psychiatric comorbidity 
(around 50%). In addition, 20% of adolescents with CDH had a 
high suicide risk (Wang et al., 2007). This association was demon-
strated in subjects with migraine with aura, but not in those with 
migraine without aura. In our epidemiological study on young 
adolescents aged 13–15, migraine with aura (adjusted OR 1.79) and 
high headache frequency (>7 days/month) (adjusted OR 1.69) were 
both associated with suicidal ideation (Wang et al., 2009).
rEstlEss lEGs sYndroME (rls)
Restless legs syndrome is a common sensorimotor disorder, and has 
long been considered related to dopaminergic system dysfunction. 
A higher prevalence of RLS (17.3–34 %) in patients with migraine 
was reported in several studies (Young et al., 2003; Rhode et al., 
2007; d’Onofrio et al., 2008). Our clinic-based study, recruiting 
1,041 patients with primary headache disorders, showed the fre-
quencies of RLS were higher in patients with migraine (11.4%) 
than those with tension-type headache (4.6%) or cluster headache 
(2.0%) (Chen et al., 2010). Migraine patients who also had RLS 
were more likely to have photophobia, phonophobia, exacerbation 
due to physical activities, vertigo, dizziness, tinnitus, and neck pain. 
They were also more likely to report disability, depression, and poor 
sleep quality. The origin of the comorbidity of RLS in migraine 
patients remains unclear. We suggest a shared dopaminergic dys-
function in the A11 nucleus as an explanation for the association 
(Chen et al., 2010).
oBEsItY
The relationship between migraine and obesity remains uncertain. 
In two population-based studies, BMI was not associated with the 
prevalence of episodic migraine (Bigal et al., 2006; Winter et al., 
2009). In addition, BMI was reported to be associated with migraine 
frequency and chronification (Bigal et al., 2006, 2007a; Winter et al., Frontiers in Neurology  |  Headache Medicine and Facial Pain    August 2010  | Volume 1  | Article 16  |  6
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hypothesized that activation of the HPA axis with reduced serotonin 
synthesis may be the link between affective disorders, migraine and 
obesity (Bigal et al., 2007b).
trEAtMEnt IMPlIcAtIons oF coMorBIdItIEs
The comorbidities should be considered when choosing acute and 
prophylactic agents for migraine treatment. Since migraine with 
aura is a well documented risk factor for CVD, conventional cardio-
vascular risk factors should be strictly controlled in these patients, 
including blood pressure control, smoking cessation and avoid-
ance of oral contraceptive agents (Bousser et al., 2000). In migraine 
patients who already have CVD, ergotamines, triptans and COX-2 
inhibitors should be avoided as acute abortive treatment. In addi-
tion, tricyclic antidepressants (TCAs) should be used with caution 
because of the risk to cause cardiac conduction abnormality. In 
migraine patients with depression, TCAs and selective norepine-
phrine re-uptake inhibitor (SNRI) are good choices for prevention, 
but flunarizine and beta-blockers should be avoided, particularly in 
the elderly because of the risk of exacerbation of depression. Of note, 
flunarizine is widely used in Europe and Asia, but not available in 
the United States. In addition, neuroleptics, selective serotonin re-
uptake inhibitors (SSRIs), SNRI, mirtazepine and flunarizine should 
be avoided in migraine patients with RLS. If migraine patients have 
comorbidities  like  epilepsy  or  bipolar  disorder,  anticonvulsants 
should be considered in a preventive treatment regimen.
FuturE dIrEctIons For rEsEArch
Large cohort studies are still needed to delineate and confirm the 
relationship between migraine and its comorbid diseases. Strict cri-
teria for the diagnoses of migraine and aura should be implemented. 
The frequency and associated symptoms should also be recorded in 
detail. The comorbidities, such as cardiovascular disease, depression 
or RLS, should also be diagnosed with clear definitions, and the well 
known risk factors for these comorbid disorders need to be control-
led. Furthermore, genetic and biological researches are important to 
investigate the shared pathophysiological mechanisms.
conclusIon
Comorbidities may emerge from population-based studies as well 
as clinical series or case-control studies. Results from the latter two 
designs must be taken into account with caution, due to the possible 
introduction of Berkson’s bias or other selection bias (Bonavita 
and De Simone, 2008). Patients with migraine, especially migraine 
with aura, are at an increased risk of CVD and psychiatric disor-
ders. Women with migraine seem to have a higher risk of CVD, 
compared to men. The association of migraine and depression and 
panic disorder is bidirectional. Young adults or adolescents with 
migraine with aura have a higher suicide risk. New data on comor-
bid RLS, epilepsy, obesity and asthma are emerging. Understanding 
the association of migraine with comorbid health conditions is 
important in providing optimal care, as well as helping understand 
the underlying mechanisms of migraine.
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migraine and irritable bowel disease was also noted in some clinical 
and epidemiological studies (Azpiroz et al., 2000; Vandvik et al., 
2004; Mulak and Paradowski, 2005; Cole et al., 2006). Based on 
a dataset of a national US health care plan, patients with irritable 
bowel syndrome had a higher OR (1.6) to have migraine, compared 
with those without (Cole et al., 2006). High frequency of celiac 
disease was also noted in migraine patients (Gabrielli et al., 2003; 
Alehan et al., 2008). In addition, one hospital-based study reported 
a high migraine frequency (12.6% vs. 5.7%) in children and young 
adults with celiac disease (Zelnik et al., 2004). These results sup-
port the conclusion that celiac disease was one comorbid disorder 
of migraine. Furthermore, chronic fatigue syndrome (Peres et al., 
2002; Tietjen et al., 2010), Raynaud’s phenomenon, systemic lupus 
erythematosus (Mizutani et al., 1985; Terwindt et al., 1998; Glanz 
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dIscussIon
The pathophysiology of the link between migraine and comorbid 
disorders is uncertain. Several possibilities have been proposed.
PossIBlE shArEd MEchAnIsMs BEtwEEn MIGrAInE wIth  
AurA And cvd
First, subjects with migraine with aura may have other traditional 
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The ACE DD genotype was reported to act in combination with 
the MTHFR T/T genotype to increase migraine susceptibility, with 
the greatest effect in those with aura (Lea et al., 2005).
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